Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3034

Actual shortage: 241 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TERAZOSIN 2MG TABLET Actual shortage 2024-04-26 2024-04-26 226330
APO-METHYLPHENIDATE 10MG TABLET Actual shortage 2024-04-26 2024-05-03 226327
APO-CITALOPRAM 20MG TABLET Actual shortage 2024-04-26 2024-04-26 226324
APO-CITALOPRAM 40MG TABLET Actual shortage 2024-04-26 2024-04-26 226321
APO-DUTASTERIDE 0.5MG CAPSULE Actual shortage 2024-04-26 2024-04-26 226318
APO-LEFLUNOMIDE 20MG TABLET Actual shortage 2024-04-26 2024-04-26 226315
APO-CITALOPRAM 20MG TABLET Actual shortage 2024-04-26 2024-04-26 226312
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Actual shortage 2024-04-26 2024-04-26 226309
APO-LITHIUM CARBONATE 150MG CAPSULE Actual shortage 2024-04-19 2024-05-03 225802
APO-GLICLAZIDE 80MG TABLET Actual shortage 2024-04-19 2024-04-19 225799
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Actual shortage 2024-04-19 2024-05-03 225796
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-26 225793
APO-TADALAFIL 10MG TABLET Actual shortage 2024-04-19 2024-04-26 225790
APO-TADALAFIL PAH 20MG TABLET Resolved 2024-04-19 2024-05-03 225785
APO-WARFARIN 1MG TABLET Actual shortage 2024-04-19 2024-04-26 225782
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225779
APO-DASATINIB 70MG TABLET Actual shortage 2024-04-19 2024-05-03 225776
APO-TADALAFIL 2.5MG TABLET Actual shortage 2024-04-19 2024-05-03 225773
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225770
APO-TRIMEBUTINE 100MG TABLET Actual shortage 2024-04-19 2024-04-19 225767

Showing 21 to 40 of 3034

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CEPHALEX 250MG TABLET Discontinued 2018-09-07 2019-02-21 60370
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN 32MG TABLET Discontinued 2018-09-07 2018-09-15 60328
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 4MG TABLET Discontinued 2018-09-07 2018-09-15 60319
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-BROMAZEPAM 3MG TABLET Discontinued 2018-09-07 2019-06-12 60307
APO-BROMAZEPAM 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BOSENTAN 125.0MG TABLET Discontinued 2018-09-07 2018-10-31 60291
APO-BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60288
APO-ATORVASTATIN 80MG TABLET Discontinued 2018-09-07 2018-12-29 60285

Showing 241 to 260 of 356